Sanginita Chemicals Limited IPO – GMP, Review, Share Price, Subscription, and Details

1.Sanginita Chemicals Limited IPO Overview

The initial public offering (IPO) of Sanginita Chemicals Limited is a public issue under the SME board. The subscription window is scheduled to open on Mar 1, 2017 and close on Mar 3, 2017, with the price band fixed at ₹22 per equity share.

2.Issue Details at a Glance

3.Bidding, Allotment & Listing Timeline

• Bidding opens: Mar 1, 2017
• Bidding closes: Mar 3, 2017
• Allotment date: TBA
• Listing date: 2019-07-15
• Minimum investment: TBA

4.Sanginita Chemicals Limited IPO GMP Today

No grey market premium has been recorded for Sanginita Chemicals Limited yet. GMP is an informal, unregulated indicator of listing-day sentiment and is not published by any exchange.

5.How to Apply for Sanginita Chemicals Limited IPO

1. 1Open IPOGMPTracker or use your broker's app or net banking ASBA facility.
2. 2Search for "Sanginita Chemicals Limited IPO" and select it from the list of current issues.
3. 3Choose your demat account and enter your bid quantity in multiples of the —-share lot, at a price within the ₹22 band (or bid at cut-off, if eligible).
4. 4Submit the application and approve the UPI mandate request when it arrives — funds stay blocked in your account and are debited only on allotment.

Allotment is expected to be finalised around TBA, with listing tentatively scheduled for 2019-07-15 on BSE and NSE. Once finalised, check your status on the Sanginita Chemicals Limited IPO allotment status page.

6.How to Track Subscription & Allotment

• Live subscription: Track QIB, NII and retail bidding on the IPO subscription status page
• Allotment status: Check your application on the IPO allotment status page
• Full IPO details: See dates, lot size, reservation and financials on the Sanginita Chemicals Limited IPO page
• More issues: Browse current IPOs, upcoming IPOs and the IPO event calendar

7.Conclusion

Sanginita Chemicals Limited opens on Mar 1, 2017 and closes on Mar 3, 2017 at ₹22 per share. Read the offer documents in full and consult a qualified adviser before applying — nothing on this page is investment advice.